首页> 外文学位 >Exploring the Rules and Therapeutic Promise of Extracellular Vesicle Mediated Intercellular Communication.
【24h】

Exploring the Rules and Therapeutic Promise of Extracellular Vesicle Mediated Intercellular Communication.

机译:探索细胞外囊泡介导的细胞间通讯的规则和治疗前景。

获取原文
获取原文并翻译 | 示例

摘要

Intercellular communication is essential to proper functioning of many biological processes. Recent evidence has now established that one form of intercellular communication occurs via the secretion of lipid vesicles known as extracellular vesicles, or EVs. EVs are capable of transferring proteins and RNAs from the cytoplasm of an EV-producing cell to the cytoplasm of a recipient cell where these RNAs and proteins have an effect on recipient cell behavior. Potentially, this mechanism of intercellular communication could be harnessed for therapeutic biomolecule delivery. To realize this potential, the rules governing EV-mediated intercellular communication must be elucidated. Many open questions exist regarding how EVs are produced, loaded with biomolecular cargo, taken up by recipient cells, and how each of these processes could be modulated for therapeutic purposes.;Here we investigate several properties of EV-mediated intercellular communication. First, we develop a Targeted and Modular EV Loading (TAMEL) platform to investigate how biophysical properties impact RNA loading into EVs and delivery of RNA cargo by EVs to recipient cells. Second, we investigate rules that limit the display of targeting peptides on the surface of EVs for targeted EV delivery to recipient cells. We demonstrate that targeting peptides are degraded by endosomal proteases and develop a glycosylation strategy for stabilizing targeting peptides on the surface of EVs. Third, we leverage EV peptide display to investigate (a) whether specific EV subsets can be enriched by affinity chromatography and (b) whether this enables enhanced cargo molecule delivery. As a whole, this work fills an important gap in understanding of EV-mediated intercellular communication and may enable novel therapeutic strategies harnessing EVs as biomolecular delivery vehicles.
机译:细胞间的通讯对于许多生物学过程的正常运作至关重要。现在的最新证据表明,一种细胞间通讯形式是通过分泌称为细胞外囊泡或EV的脂质囊泡而发生的。 EV能够将蛋白质和RNA从产生EV的细胞的细胞质转移到受体细胞的细胞质,其中这些RNA和蛋白质会影响受体细胞的行为。潜在地,可以利用这种细胞间通讯机制来治疗性生物分子的传递。为了实现这一潜力,必须阐明管理EV介导的细胞间通讯的规则。关于电动汽车如何生产,如何装载生物分子货物,被受体细胞吸收以及如何为治疗目的调节这些过程,存在许多悬而未决的问题。在这里,我们研究了电动汽车介导的细胞间通讯的几种特性。首先,我们开发了靶向和模块化电动汽车装载(TAMEL)平台,以研究生物物理特性如何影响RNA装载到电动汽车中以及电动汽车将RNA货物运送到受体细胞的过程。其次,我们研究了限制靶向肽在电动汽车表面上展示的规则,以将靶向电动车递送至受体细胞。我们证明了靶向肽被内体蛋白酶降解,并开发了用于稳定电动汽车表面上靶向肽的糖基化策略。第三,我们利用EV肽展示来研究(a)是否可以通过亲和层析富集特定的EV亚型,以及(b)是否可以增强货物分子的递送。总体而言,这项工作填补了对EV介导的细胞间通讯的理解的重要空白,并且可能使利用EV作为生物分子传递载体的新型治疗策略成为可能。

著录项

  • 作者

    Hung, Michelle E.;

  • 作者单位

    Northwestern University.;

  • 授予单位 Northwestern University.;
  • 学科 Cellular biology.
  • 学位 Ph.D.
  • 年度 2016
  • 页码 174 p.
  • 总页数 174
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号